SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Fluidigm Corporation (NASDAQ:FLDM) today announced commercial availability of a new high throughput single-cell mRNA sequencing workflow for its C1TM system to enable large-scale studies to characterize heterogeneous samples. This validated workflow includes a new advanced integrated ...
Read More »QuantSeq 3’ mRNA sequencing for RNA quantification
With the rapid development of NGS technologies, RNA-seq has become the new standard for transcriptome analysis. Although the price per base has been substantially reduced, sample preparation, sequencing and data processing are major cost factors in high throughput screenings. QuantSeq ...
Read More »